Acetylation of endogenous STAT proteins

Methods in Molecular Biology

Volumn 967, Issue , 2013, Pages 167-178

  Ginter, Torsten ^a   Heinzel, Thorsten ^a   Krämer, Oliver H ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Acetylation; HAT; HDACi; IFN; Immunoprecipitation; STAT; STAT1

Indexed keywords

STAT PROTEIN; STAT1 PROTEIN; CELL EXTRACT; LYSINE;

ANIMAL CELL; AQUEOUS SOLUTION; CELL LYSATE; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PROTEIN ACETYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; WESTERN BLOTTING; ACETYLATION; ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY;

ACETYLATION; ANIMALS; BLOTTING, WESTERN; CELL EXTRACTS; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOPRECIPITATION; LYSINE; MICE; STAT TRANSCRIPTION FACTORS; STAT1 TRANSCRIPTION FACTOR;

EID: 84878769838     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-242-1_12     Document Type: Chapter

References (41)

1. Yang XJ, Seto E (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26(37):5310–5318.
2. Buchwald M, Krämer OH, Heinzel T (2009) HDACi–targets beyond chromatin. Cancer Lett 280(2):160–167.
3. Spange S et al (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 41(1):185–198.
4. Krämer OH (2009) HDAC2: a critical factor in health and disease. Trends Pharmacol Sci 30(12):647–655.
5. Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5(9):769–784.
6. Sakuma T et al (2006) Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol 29(1):117–124.
7. Wilson AJ et al (2006) Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 281(19):13548–13558.
8. Müller S, Krämer OH (2010) Inhibitors of HDACs–effective drugs against cancer? Curr Cancer Drug Targets 10(2):210–228.
9. Bradner JE et al (2010) Chemical phylogenetics of histone deacetylases. Nat Chem Biol 6(3):238–243.
10. Bitterman KJ et al (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 277(47):45099–45107.
11. Krämer OH et al (2006) Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev 20(4):473–485.
12. Reich NC (2007) STAT dynamics. Cytokine Growth Factor Rev 18(5–6):511–518.
13. Mertens C, Darnell JE Jr (2007) SnapShot: JAK-STAT signaling. Cell 131(3):612.
14. Hu X, Ivashkiv LB (2009) Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31(4):539–550.
15. Kim HS, Lee MS (2007) STAT1 as a key modulator of cell death. Cell Signal 19(3):454–465.
16. Yuan ZL et al (2005) Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307(5707):269–273.
17. Ray S, Boldogh I, Brasier AR (2005) STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology 129(5):1616–1632.
18. Cudejko C et al (2011) p16INK4a-deficiency promotes IL-4-induced polarization and inhibits pro-inflammatory signaling in macrophages. Blood 118(9):2556–2566.
19. Stronach EA et al (2011) HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer. Cancer Res 71(13):4412–4422.
20. Guo L et al (2007) Stat1 acetylation inhibits inducible nitric oxide synthase expression in interferon-gamma-treated RAW264.7 murine macrophages. Surgery 142(2):156–162.
21. Hayashi T et al (2007) IFN-gamma protects cerulein-induced acute pancreatitis by repressing NF-kappa B activation. J Immunol 178(11):7385–7394.
22. Krämer OH et al (2009) A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev 23(2):223–235.
23. Tang X et al (2007) Acetylation-dependent signal transduction for type I interferon receptor. Cell 131(1):93–105.
24. Ginter T et al (2012) Histone deacetylase inhibitors block IFNgamma-induced STAT1 phosphorylation. Cell Signal 24(7):1453–1460.
25. Genin P, Morin P, Civas A (2003) Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A. J Virol 77(12):7113–7119.
26. Sakamoto S, Potla R, Larner AC (2004) Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. J Biol Chem 279(39):40362–40367.
27. Nusinzon I, Horvath CM (2003) Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc Natl Acad Sci USA 100(25):14742–14747.
28. Chang HM et al (2004) Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc Natl Acad Sci U S A 101(26):9578–9583.
29. Klampfer L et al (2004) Requirement of histone deacetylase activity for signaling by STAT1. J Biol Chem 279(29):30358–30368.
30. Klampfer L et al (2003) Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. Mol Cancer Res 1(11):855–862.
31. Krämer OH, Heinzel T (2010) Phosphorylation-acetylation switch in the regulation of STAT1 signaling. Mol Cell Endocrinol 315(1–2):40–48.
32. Dormeyer W, Ott M, Schnolzer M (2005) Probing lysine acetylation in proteins: strategies, limitations, and pitfalls of in vitro acetyltransferase assays. Mol Cell Proteomics 4(9):1226–1239.
33. Hay RT (2005) SUMO: a history of modification. Mol Cell 18(1):1–12.
34. Choudhary C et al (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325(5942):834–840.
35. Sonnemann J et al (2010) Serine proteases in histone deacetylase inhibitor-induced apoptosis. Mol Cancer Ther 9(8):2440–2441, author reply 2441–2.
36. Li M et al (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277(52):50607–50611.
37. Wang R, Cherukuri P, Luo J (2005) Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem 280(12):11528–11534.
38. Nie Y et al (2009) STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol 11(4):492–500.
39. Nadiminty N et al (2006) Stat3 activation of NF-kappa B p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci U S A 103(19):7264–7269.
40. Ma L et al (2010) Acetylation modulates prolactin receptor dimerization. Proc Natl Acad Sci U S A 107(45):19314–19319.
41. Shankaranarayanan P et al (2001) Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J Biol Chem 276(46):42753–42760.